These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 29484719)
21. DNA decorated Cu Liang S; Xie Z; Wei Y; Cheng Z; Han Y; Lin J Dalton Trans; 2018 Jun; 47(24):7916-7924. PubMed ID: 29790525 [TBL] [Abstract][Full Text] [Related]
22. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line. Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815 [No Abstract] [Full Text] [Related]
23. A low-intensity focused ultrasound-assisted nanocomposite for advanced triple cancer therapy: local chemotherapy, therapeutic extracellular vesicles and combined immunotherapy. Tan M; Chen Y; Guo Y; Yang C; Liu M; Guo D; Wang Z; Cao Y; Ran H Biomater Sci; 2020 Dec; 8(23):6703-6717. PubMed ID: 33108411 [TBL] [Abstract][Full Text] [Related]
24. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release. Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840 [TBL] [Abstract][Full Text] [Related]
25. MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma. Zhao P; Wu S; Cheng Y; You J; Chen Y; Li M; He C; Zhang X; Yang T; Lu Y; Lee RJ; He X; Xiang G Nanomedicine; 2017 Nov; 13(8):2507-2516. PubMed ID: 28577837 [TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin. Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765 [TBL] [Abstract][Full Text] [Related]
27. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
28. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin. Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505 [TBL] [Abstract][Full Text] [Related]
29. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells. Kashyap S; Singh N; Surnar B; Jayakannan M Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038 [TBL] [Abstract][Full Text] [Related]
30. Near-infrared-light induced nanoparticles with enhanced tumor tissue penetration and intelligent drug release. Zhang Y; Liu Y; Gao X; Li X; Niu X; Yuan Z; Wang W Acta Biomater; 2019 May; 90():314-323. PubMed ID: 30981751 [TBL] [Abstract][Full Text] [Related]
32. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles. Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991 [TBL] [Abstract][Full Text] [Related]
33. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304 [TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids. Yang G; Fu S; Yao W; Wang X; Zha Q; Tang R J Colloid Interface Sci; 2017 Oct; 504():25-38. PubMed ID: 28527297 [TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
36. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy. Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810 [TBL] [Abstract][Full Text] [Related]
37. Dual-Responsive and Deep-Penetrating Nanomicelles for Tumor Therapy via Extracellular Matrix Degradation and Oxidative Stress. Wang Z; Xu Y; Wu G; Zuo T; Zhang J; Yang J; Yang Y; Fang T; Shen Q ACS Biomater Sci Eng; 2021 Jan; 7(1):166-179. PubMed ID: 33372514 [TBL] [Abstract][Full Text] [Related]
38. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles. Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730 [TBL] [Abstract][Full Text] [Related]
39. [Polyelectrolyte layer-by-layer assembled lipid nanoparticles for improving oral absorption of doxorubicin]. Shen AJ; Xia DN; Gan Y; Li J Yao Xue Xue Bao; 2016 Jul; 51(7):1136-43. PubMed ID: 29897223 [TBL] [Abstract][Full Text] [Related]